✦ LIBER ✦

Long-term intraduodenal infusion of a water based levodopa-carbidopa dispersion in very advanced Parkinson's disease

✍ Scribed by D. Nilsson; L.-E. Hansson; K. Johansson; C. Nystrom; L. Paalzow; S.-M. Aquilonius

Book ID: 109336762
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 891 KB
Volume: 97
Category: Article
ISSN: 0001-6314
DOI: 10.1111/j.1600-0404.1998.tb00633.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Levodopa/carbidopa intestinal gel infusi

Levodopa/carbidopa intestinal gel infusion long-term therapy in advanced Parkinson’s disease

✍ D. Nyholm; K. Klangemo; A. Johansson 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 540 KB

Interim analysis of long-term intraduode

Interim analysis of long-term intraduodenal levodopa infusion in advanced Parkinson disease

✍ S. E. Pålhagen; N. Dizdar; T. Hauge; B. Holmberg; R. Jansson; J. Linder; D. Nyho 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB

Long-term levodopa/carbidopa infusion ef

Long-term levodopa/carbidopa infusion effective in Parkinson's disease

✍ Carlson, Bob 📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB

Intraduodenal infusion of a water-based

Intraduodenal infusion of a water-based levodopa dispersion for optimisation of the therapeutic effect in severe Parkinson's disease

✍ E. Bredberg; D. Nilsson; K. Johansson; S. M. Aquilonius; B. Johnels; C. Nyström; 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 614 KB

Motor performance of five patients with advanced Parkinson's disease was investigated during their optimum oral therapy (conventional tablets and/or depot capsules) and during a continuous duodenal infusion of levodopa. Due to the low water solubility of the drug, conventional tablets of levodopa+ca

A long-term, open-label study of levodop

A long-term, open-label study of levodopa–/INS;carbidopa intestinal gel in advanced Parkinson's disease patients: safety and motor-symptom endpoints

✍ Espay, A.J.; Odin, P.; Fernandez, H.H.; Hauser, R.A.; Standaert, D.G.; Lang, A.E 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 62 KB

A long-term, open-label study of levodop

A long-term, open-label study of levodopa–/INS;carbidopa intestinal gel in advanced Parkinson's disease patients: Functional and health-related quality-of-life endpoints

✍ Standaert, D.G.; Fernandez, H.H.; Odin, P.; Hauser, R.A.; Espay, A.J.; Steiger, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 76 KB